| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | tacrolimus | CTRPv2 | pan-cancer | AAC | 0.048 | 0.2 |
| mRNA | etoposide | GDSC1000 | pan-cancer | AAC | 0.046 | 0.2 |
| mRNA | Bexarotene | GDSC1000 | pan-cancer | AAC | 0.047 | 0.2 |
| mRNA | BRD1812 | CTRPv2 | pan-cancer | AAC | -0.048 | 0.2 |
| mRNA | BMS-536924 | GDSC1000 | pan-cancer | AAC | -0.043 | 0.2 |
| mRNA | ML006 | CTRPv2 | pan-cancer | AAC | -0.05 | 0.2 |
| mRNA | BRD-K96431673 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.2 |
| mRNA | BRD1835 | CTRPv2 | pan-cancer | AAC | -0.051 | 0.2 |
| mRNA | EKB-569 | GDSC1000 | pan-cancer | AAC | 0.042 | 0.2 |
| mRNA | BRD6340 | CTRPv2 | pan-cancer | AAC | -0.046 | 0.2 |